What Avandia means for drug time to market; Specialty police resolve Albuterol theft;

> The Avandia controversy, which reignites the debate over whether the FDA should do more to ensure the safety of drugs prior to approval, will necessarily complicate efforts to speed the drug approval process. Article

> A specialty police group has recovered a load of 35,000 albuterol vials, worth $500,000, stolen a year ago in transit between a manufacturing site in South Carolina and a Texas distribution center. Article

> EirGen Pharma applies Six Sigma and ICH Q9 for high-potency drug processes. 10-minute video

> Lonza Group has been contracted to produce supplies of Benlysta, a lupus treatment being developed by Human Genome Sciences and GlaxoSmithKline for the U.S. and European markets. Release

> Cell Therapeutics has signed a five-year deal with NerPharMa DS in which the Italian drug company will manufacture the Seattle biotech's cancer drug Pixantrone. Release

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.